WHO ICTRP trial

Comparison of Segmentectomy Versus Lobectomy for Lung Adenocarcinoma <= 2cm with…

ChiCTR1800017322 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting

Key facts

Trial ID ChiCTR1800017322
Public title Comparison of Segmentectomy Versus Lobectomy for Lung Adenocarcinoma <= 2cm with Micropapillary and Solid Subtype Negative by Intraoperative Frozen Sections: a Prospective and Multi-Center Randomized Controlled Trial Study
Scientific title Comparison of Segmentectomy Versus Lobectomy for Lung Adenocarcinoma <= 2cm with Micropapillary and Solid Subtype Negative by Intraoperative Frozen Sections: a Prospective and Multi-Center Randomized Controlled Trial Study
Primary sponsor Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai
Registry Chinese Clinical Trial Registry (ChiCTR)
Recruitment status Recruiting
Study type Interventional study
Phase 3
Countries China
Conditions early-stage lung adenocarcinoma
Interventions Experimental group:Segmentectomy with systemic lymph node dissection;Control group:Lobectomy with systemic lymph node dissection
Registration date Jul 24, 2018
Target size Experimental group:345;Control group:345
Registry page chictr.org.cn

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations